The AbM numbering scheme refers to the standardized system for naming monoclonal antibodies (mAbs) based on their source, target, and characteristics. This system is regulated by the World Health Organization (WHO) and follows a specific structure to help identify the antibody's origin, function, and target in a consistent manner. This naming system ensures clarity about the function, source, and use of monoclonal antibodies in clinical and scientific contexts.